-
MRTX-1257
- names:
MRTX-1257
- CAS号:
2206736-04-9
MDL Number: - MF(分子式): C33H39N7O2 MW(分子量): 565.71
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM004292-10mg | 10mg | 98.62% | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | ||
| YZM004292-5mg | 5mg | 98.62% | ¥ 4550.00 | ¥ 4550.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 2206736-04-9 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C33H39N7O2 |
| 分子量 Molecular Weight | 565.71 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度55 mg/mL(97.22 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble) |
| 性状 | |
| 储藏条件 Storage conditions | -20°C, stored under nitrogen * In solvent : -80°C, 6 months月; -20°C, 1 month月 (stored under nitrogen) |
MRTX-1257(CAS:2206736-04-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | MRTX-1257 为选择性的、不可逆的、共价的并具有口服活性的KRAS G12C抑制剂,其在 H358 细胞中测得 KRAS 依赖 ERK 磷酸化的IC50值为 900 pM |
| Introduction | MRTX257 is a selective, irreversible, covalent and oral activeKRAS G12Cinhibitor, with anIC50of 900 pM for KRAS dependent ERK phosphorylation in H358 cells. |
| Application1 | |
| Application2 | |
| Application3 |
MRTX-1257 为选择性的、不可逆的、共价的并具有口服活性的KRAS G12C抑制剂,其在 H358 细胞中测得 KRAS 依赖 ERK 磷酸化的IC50值为 900 pM。MRTX-1257 is a selective, irreversible, covalent and oral activeKRAS G12Cinhibitor, with anIC50of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1].
【1】.Matthew et al. Structure-Based Drug Discovery of MRTX1257, a Selective, Covalent KRAS G12C Inhibitor with Oral Activity in Animal Models of Cancer.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


